- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana AB appoints new Chief Financial Officer
Dignitana AB announces that the Company has hired Karin Almqvist Liwendahl as Chief Financial Officer, effective November 1, 2020. Karin currently serves as CFO for Sprint Bioscience and has over 20 years of broad finance experience working for global companies in the telecom and life science industries. Karin has held international CFO and Managing Director positions within Telia and further past roles also include Director of Investor Relations for Ericsson.
“Ensuring we maintain strong relationships with our shareholders and capital markets partner across Sweden is a very important function for Dignitana,” said William Cronin, CEO. “Karin’s leadership and extensive experience in the global marketplace will ensure that Dignitana can utilize all available financial resources as we expand our presence throughout Europe and beyond.”
“Dignitana is in a high-growth phase and addressing the challenges that come with rapidly expanding demand,” said Karin Almqvist Liwendahl. “I am eager to join the Dignitana team and look forward to contributing my experience to support the Company’s growth.”
Dignitana’s Interim CFO, Jonas Sohlman, has provided excellent guidance to the company since April 2020 and will remain involved to transition finance functions to Karin.
Sweden-based Dignitana is the world leader in scalp cooling innovation and the DigniCap Scalp Cooling System is available in 40 countries around the globe.
For More Information Contact
Melissa Bourestom, VP Corporate Communications firstname.lastname@example.org +1 469-518-5031
About DignitanaDignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Certified Adviser is Redeye AB, +46 8 121 576 90, email@example.com www.redeye.se